Pharma
Coempaken (Empagliflozin 12.5 mg / Metformin HCl 500 mg)
Antidiabetic combination; Empagliflozin 12.5 mg and Metformin 500 mg (28 tablets) for Type 2 Diabetes management.
Coempaken (Empagliflozin 12.5 mg / Metformin HCl 500 mg)
Coempaken is a combination medication containing Empagliflozin and Metformin HCl. Empagliflozin is an SGLT2 inhibitor that helps the kidneys get rid of glucose from your bloodstream. Metformin is a biguanide that lowers glucose production in the liver and improves insulin sensitivity. This pack contains 28 tablets (4x7 Tablets). It is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. Common side effects include urinary tract infections and gastrointestinal upset.
You May Also Like
Antihypertensive and alpha-2 agonist; 0.1 mg tablets for blood pressure and ADHD management.
Combination antidiabetic agent; 2.5 mg Linagliptin and 1000 mg Metformin tablets for Type 2 Diabetes management.
Combination DPP-4 inhibitor and Biguanide; 50 mg/850 mg Sitagliptin/Metformin tablets for Type 2 Diabetes.
High-strength immunosuppressant; 100 mg Cyclosporine soft gelatin capsules for transplant maintenance.